Tropicamide Versus Cyclopentolate For Cycloplegic Refraction in Pediatric Patients with Brown Irides: A Randomized Clinical Trial
Cycloplegic refraction remains the gold standard for determining refractive errors in children, and it is achieved by using pharmacological agents that temporarily paralyze the ciliary muscle. Active accommodation in children is the primary source of error in measurements, and many studies on the pediatric population have shown that a lack of cycloplegia may result in an overestimation of myopia and an underestimation of hyperopia. The differences are particularly large for hyperopic errors and smaller for emmetropic, myopic, and astigmatic errors. (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - October 3, 2023 Category: Opthalmology Authors: Wejdan Al-Thawabieh, Rami Al-Omari, Diala Walid Abu-Hassan, Mohammad T. Abuawwad, Abdullah Al-awadhi, Hashem Abu Serhan Tags: Original Articles Source Type: research
United States Regulatory Approval of Topical Treatments for Dry Eye
To report the heterogeneity in methodology of clinical trials submitted to the U.S. Food and Drug Administration (FDA) for approval of topical dry eye treatments. (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - October 2, 2023 Category: Opthalmology Authors: David Cui, Ian J. Saldanha, Gavin Li, Priya M. Mathews, Michael X. Lin, Esen K. Akpek Tags: Original Articles Source Type: research
Striving Toward Better Eye Health Beyond Our Waiting Rooms: The LXXX Edward Jackson Memorial Lecture
Visual impairment (VI) negatively impacts the quality of lives of individuals and the optimal health of populations, creating both human and financial costs. Yet, VI has not risen to a level that is considered a priority in population health. This analysis assesses the evidence currently available for strengthening the value proposition for eye health, particularly the demographic characteristics and patient-centered outcomes found in clinical research. (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 28, 2023 Category: Opthalmology Authors: Eve J. Higginbotham Source Type: research
Striving Toward Better Eye Health Beyond Our Waiting Rooms
Visual impairment (VI) negatively impacts the quality of lives of individuals and the optimal health of populations, creating both human and financial costs. Yet, VI has not risen to a level that is considered a priority in population health. This analysis assesses the evidence currently available for strengthening the value proposition for eye health, particularly the demographic characteristics and patient-centered outcomes found in clinical research. (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 28, 2023 Category: Opthalmology Authors: Eve J. Higginbotham Tags: Original Articles Source Type: research
Infectious and Noninfectious Corneal Ulcers in Ocular Graft-Versus-Host Disease: Epidemiology, Clinical Characteristics, and Outcomes
To evaluate the incidence, clinical characteristics, microbiological profile, and therapeutic outcomes of corneal ulcers in individuals with chronic ocular graft-vs-host disease (coGVHD). (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 27, 2023 Category: Opthalmology Authors: Paula A. Sepulveda-Beltran, Piero Carletti, Victor Banda, Lakshman Mulpuri, Harry Levine, Guillermo Amescua, Trent P. Wang, Anat Galor, Rahul Tonk Source Type: research
Magnetic Resonance Imaging of Globe Translation in Abducens Palsy
This study aimed to test this proposition by evaluating globe translation during horizontal duction in abducens palsy. (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 27, 2023 Category: Opthalmology Authors: Changzoo Kim, Joseph L. Demer Source Type: research
Infectious and Non-infectious Corneal Ulcers in Ocular Graft-Versus-Host Disease: Epidemiology, Clinical Characteristics and Outcomes
To evaluate the incidence, clinical characteristics, microbiological profile, and therapeutic outcomes of corneal ulcers in individuals with chronic ocular graft-vs-host disease (coGVHD). (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 27, 2023 Category: Opthalmology Authors: Paula A. Sepulveda-Beltran, Piero Carletti, Victor Banda, Lakshman Mulpuri, Harry Levine, Guillermo Amescua, Trent P. Wang, Anat Galor, Rahul Tonk Source Type: research
Disparities in Promotion and Retention Rates Among Underrepresented in Medicine Faculty in U.S. Ophthalmology Departments
This study examines the rates and trends of faculty promotions within the field of ophthalmology, with comparative emphasis on the rates of promotion among URiM faculty. (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 25, 2023 Category: Opthalmology Authors: Adanna Udeh, Dana Huh, Terri Young, O'Rese Knight, Fasika Woreta Tags: Original Articles Source Type: research
Drusen and other retinal findings in people with IgA glomerulonephritis
We examined the frequency of drusen in IgA nephropathy, and compared their location and composition with those for drusen in age-related macular degeneration. (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 25, 2023 Category: Opthalmology Authors: Ursula Greferath, Erica Fletcher, Judy Savige, Heather G Mack Tags: Original Articles Source Type: research
Masthead
(Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 23, 2023 Category: Opthalmology Source Type: research
Editorial Board
(Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 23, 2023 Category: Opthalmology Source Type: research
Table of Contents
(Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 23, 2023 Category: Opthalmology Source Type: research
Comorbidity of Ocular and Facial Demodicosis
Demodex mites are saprophytic ectoparasites that reside in pilosebaceous units. Among the genus Demodex, only two species, Demodex folliculorum and Demodex brevis, are found on human skin, preferably in the facial skin and eyelids.1,2 While D. folliculorum resides mainly in the follicular infundibulum, D. brevis burrows in the deeper sebaceous glands.3 Overgrowth of these mites may results in "demodicosis", an immunological or allergic condition.4 (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 20, 2023 Category: Opthalmology Authors: Wei-Lun Huang, Chang-Ming Huang, Chia-Yu Chu, Fung-Rong Hu Tags: Original Articles Source Type: research
Noninfectious Uveitis Risk After COVID-19 Vaccination: A Nationwide Retrospective Cohort Study
Since the onset of the global COVID-19 pandemic, a rapid surge in the number of cases during the initial outbreak precipitated the prompt development and distribution of vaccines for the general population. As of April 2023, 69.8% of the world's population has received ≥1 dose of a COVID-19 vaccine,1 and in the Republic of Korea, 87.6% of the population (approximately 44.8 million individuals) has received ≥1 dose.2 (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 19, 2023 Category: Opthalmology Authors: Myung Soo Chang, Hae Rang Kim, Sunyeup Kim, Christopher Seungkyu Lee, Suk Ho Byeon, Sung Soo Kim, Seung Won Lee, Yong Joon Kim Tags: Original articles Source Type: research
Non-infectious uveitis risk after Coronavirus Disease 2019 (COVID-19) vaccination: A nationwide retrospective cohort study
Since the onset of the global coronavirus disease 2019 (COVID-19) pandemic, a rapid surge in the number of cases during the initial outbreak precipitated the prompt development and distribution of vaccines for the general population. As of April 2023, 69.8% of the world's population has received at least one dose of a COVID-19 vaccine,1 and in the Republic of Korea, 87.6% of the population (approximately 44.8 million individuals) has received at least one dose.2 (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - September 19, 2023 Category: Opthalmology Authors: Myung Soo Chang, Hae Rang Kim, Sunyeop Kim, Christopher Seungkyu Lee, Suk Ho Byeon, Sung Soo Kim, Seung Won Lee, Yong Joon Kim Tags: Original Articles Source Type: research
